176 related articles for article (PubMed ID: 10805381)
1. A role for SSeCKS, a major protein kinase C substrate with tumour suppressor activity, in cytoskeletal architecture, formation of migratory processes, and cell migration during embryogenesis.
Gelman IH; Tombler E; Vargas J
Histochem J; 2000 Jan; 32(1):13-26. PubMed ID: 10805381
[TBL] [Abstract][Full Text] [Related]
2. Control of cytoskeletal architecture by the src-suppressed C kinase substrate, SSeCKS.
Gelman IH; Lee K; Tombler E; Gordon R; Lin X
Cell Motil Cytoskeleton; 1998; 41(1):1-17. PubMed ID: 9744295
[TBL] [Abstract][Full Text] [Related]
3. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
Xia W; Unger P; Miller L; Nelson J; Gelman IH
Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells.
Nelson PJ; Moissoglu K; Vargas J; Klotman PE; Gelman IH
J Cell Sci; 1999 Feb; 112 ( Pt 3)():361-70. PubMed ID: 9885289
[TBL] [Abstract][Full Text] [Related]
5. SSeCKS gene expression in vascular smooth muscle cells: regulation by angiotensin II and a potential role in the regulation of PAI-1 gene expression.
Coats SR; Covington JW; Su M; Pabón-Peña LM; Eren M; Hao Q; Vaughan DE
J Mol Cell Cardiol; 2000 Dec; 32(12):2207-19. PubMed ID: 11112996
[TBL] [Abstract][Full Text] [Related]
6. Cell-cycle regulated expression and serine phosphorylation of the myristylated protein kinase C substrate, SSeCKS: correlation with culture confluency, cell cycle phase and serum response.
Nelson PJ; Gelman IH
Mol Cell Biochem; 1997 Oct; 175(1-2):233-41. PubMed ID: 9350056
[TBL] [Abstract][Full Text] [Related]
7. SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D.
Lin X; Nelson P; Gelman IH
Mol Cell Biol; 2000 Oct; 20(19):7259-72. PubMed ID: 10982843
[TBL] [Abstract][Full Text] [Related]
8. Reexpression of the major protein kinase C substrate, SSeCKS, suppresses v-src-induced morphological transformation and tumorigenesis.
Lin X; Gelman IH
Cancer Res; 1997 Jun; 57(11):2304-12. PubMed ID: 9187136
[TBL] [Abstract][Full Text] [Related]
9. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway.
Su B; Bu Y; Engelberg D; Gelman IH
J Biol Chem; 2010 Feb; 285(7):4578-86. PubMed ID: 20018890
[TBL] [Abstract][Full Text] [Related]
10. Control of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12.
Guo LW; Gao L; Rothschild J; Su B; Gelman IH
J Biol Chem; 2011 Nov; 286(44):38356-38366. PubMed ID: 21903576
[TBL] [Abstract][Full Text] [Related]
11. Adhesion-mediated cytoskeletal remodeling is controlled by the direct scaffolding of Src from FAK complexes to lipid rafts by SSeCKS/AKAP12.
Su B; Gao L; Meng F; Guo LW; Rothschild J; Gelman IH
Oncogene; 2013 Apr; 32(16):2016-26. PubMed ID: 22710722
[TBL] [Abstract][Full Text] [Related]
12. Induction of Src-suppressed C kinase substrate (SSeCKS) in vascular endothelial cells by bacterial lipopolysaccharide.
Kitamura H; Okita K; Fujikura D; Mori K; Iwanaga T; Saito M
J Histochem Cytochem; 2002 Feb; 50(2):245-55. PubMed ID: 11799143
[TBL] [Abstract][Full Text] [Related]
13. A novel src- and ras-suppressed protein kinase C substrate associated with cytoskeletal architecture.
Lin X; Tombler E; Nelson PJ; Ross M; Gelman IH
J Biol Chem; 1996 Nov; 271(45):28430-8. PubMed ID: 8910468
[TBL] [Abstract][Full Text] [Related]
14. The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development .
Gelman IH
Front Biosci; 2002 Aug; 7():d1782-97. PubMed ID: 12133808
[TBL] [Abstract][Full Text] [Related]
15. Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS.
Lin X; Gelman IH
Biochem Biophys Res Commun; 2002 Feb; 290(5):1368-75. PubMed ID: 11820772
[TBL] [Abstract][Full Text] [Related]
16. SSeCKS/Gravin/AKAP12 metastasis suppressor inhibits podosome formation via RhoA- and Cdc42-dependent pathways.
Gelman IH; Gao L
Mol Cancer Res; 2006 Mar; 4(3):151-8. PubMed ID: 16547152
[TBL] [Abstract][Full Text] [Related]
17. Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia.
Akakura S; Huang C; Nelson PJ; Foster B; Gelman IH
Cancer Res; 2008 Jul; 68(13):5096-103. PubMed ID: 18593908
[TBL] [Abstract][Full Text] [Related]
18. SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis.
Liu Y; Gao L; Gelman IH
BMC Cancer; 2006 Apr; 6():105. PubMed ID: 16638134
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-induced, FAK-dependent tyrosine phosphorylation of the SSeCKS scaffolding protein.
Xia W; Gelman IH
Exp Cell Res; 2002 Jul; 277(2):139-51. PubMed ID: 12083796
[TBL] [Abstract][Full Text] [Related]
20. Ligand-specific control of src-suppressed C kinase substrate gene expression.
Coats SR; Pabón-Peña LM; Covington JW; Vaughan DE
Biochem Biophys Res Commun; 2002 Oct; 297(5):1112-20. PubMed ID: 12372401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
